Lysosomal Abnormalities in Cardiovascular Disease

Int J Mol Sci. 2020 Jan 27;21(3):811. doi: 10.3390/ijms21030811.

Abstract

The lysosome, a key organelle for cellular clearance, is associated with a wide variety of pathological conditions in humans. Lysosome function and its related pathways are particularly important for maintaining the health of the cardiovascular system. In this review, we highlighted studies that have improved our understanding of the connection between lysosome function and cardiovascular diseases with an emphasis on a recent breakthrough that characterized a unique autophagosome-lysosome fusion mechanism employed by cardiomyocytes through a lysosomal membrane protein LAMP-2B. This finding may impact the development of future therapeutic applications.

Keywords: Danon disease; autophagy; cardiovascular disease; lysosome function.

Publication types

  • Review

MeSH terms

  • Animals
  • Autophagosomes / metabolism
  • Autophagy
  • Cardiovascular Diseases / diagnosis
  • Cardiovascular Diseases / etiology*
  • Cardiovascular Diseases / metabolism*
  • Cardiovascular Diseases / therapy
  • Disease Management
  • Disease Susceptibility*
  • Genetic Predisposition to Disease
  • Genetic Therapy
  • Glycogen Storage Disease Type IIb / diagnosis
  • Glycogen Storage Disease Type IIb / etiology
  • Glycogen Storage Disease Type IIb / metabolism
  • Humans
  • Lysosomal-Associated Membrane Protein 2 / genetics
  • Lysosomal-Associated Membrane Protein 2 / metabolism
  • Lysosomes / metabolism*
  • Membrane Fusion
  • Membrane Proteins
  • Mutation
  • Myocytes, Cardiac / metabolism
  • Phenotype

Substances

  • Lysosomal-Associated Membrane Protein 2
  • Membrane Proteins